Form 4: BioLife Solutions CMO Sells Shares for Tax Obligations

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 351 shares of common stock to cover tax withholding obligations from restricted stock vesting.

Summary

• Todd Berard, Chief Marketing Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a sale of common stock.
• The transaction involved the disposition of 351 shares of common stock.
• The sale occurred on November 25, 2025, at a price of $26.74 per share.
• Following this transaction, Todd Berard beneficially owns 133,266 shares of common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted on February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, pre-planned insider sale for tax purposes, not indicative of management's view on the company's future performance or a significant change in beneficial ownership.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine event for publicly traded companies, often occurring when executives' restricted stock vests and shares are sold to cover tax liabilities. It does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, tax-related sale and not a discretionary sale indicating a change in confidence. The number of shares sold is a small fraction of the total shares beneficially owned by the officer.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned sale of a small number of shares by a Chief Marketing Officer to cover tax obligations related to restricted stock vesting. Such transactions are common and do not typically reflect a change in the insider's confidence in the company's prospects or fundamental value. Therefore, this specific filing does not provide new information that would warrant a change in an investor's existing position, leading to a 'hold' recommendation based solely on this report.

Keywords

BioLife Solutions, BLFS, Insider Trading, Form 4, Stock Sale, Todd Berard, Chief Marketing Officer, 10b5-1 Plan, Tax Withholding, Restricted Stock